Increased PKA signaling disrupts recognition memory and spatial memory: Role in Huntington's disease

Human Molecular Genetics

Volumn 20, Issue 21, 2011, Pages 4232-4247

  Giralt, Albert ^a,b,c   Saavedra, Ana ^a,b,c   Carretón, Olga ^a,b,c   Xifró, Xavier ^a,b,c,d   Alberch, Jordi ^a,b,c   Pérez navarro, Esther ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d UNIVERSITY OF GIRONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCINEURIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PHOSPHODIESTERASE 4A1; PHOSPHODIESTERASE 4A5; PHOSPHODIESTERASE 4AX; PHOSPHODIESTERASE 4D1; PHOSPHODIESTERASE 4D3; PHOSPHODIESTERASE IV; PROTEIN TYROSINE PHOSPHATASE; ROLIPRAM; TAU PROTEIN; TUBULIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; HIPPOCAMPUS; HUNTINGTON CHOREA; LEARNING DISORDER; LONG TERM MEMORY; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPATIAL MEMORY; SYMPTOM; TASK PERFORMANCE; UPREGULATION; WILD TYPE;

ANIMALS; CALCINEURIN; COGNITION DISORDERS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DISEASE PROGRESSION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HIPPOCAMPUS; HUMANS; HUNTINGTON DISEASE; MALE; MEMORY; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; PHOSPHODIESTERASE 4 INHIBITORS; PROTEIN ISOFORMS; RECOGNITION (PSYCHOLOGY); REPRODUCIBILITY OF RESULTS; ROLIPRAM; SIGNAL TRANSDUCTION; TIME FACTORS;

ANIMALIA; MUS;

EID: 80053960641     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr351     Document Type: Article

References (81)

1. The Huntington's Disease Collaborative Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
2. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. and Richardson, E.P. Jr (1985) Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol., 44, 559-577.
3. Rosas, H.D., Koroshetz, W.J., Chen, Y.I., Skeuse, C., Vangel, M., Cudkowicz, M.E., Caplan, K., Marek, K., Seidman, L.J., Makris, N. et al. (2003) Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology, 60, 1615-1620.
4. Foroud, T., Siemers, E., Kleindorfer, D., Bill, D.J., Hodes, M.E., Norton, J.A., Conneally, P.M. and Christian, J.C. (1995) Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann. Neurol., 37, 657-664.
5. Lawrence, A.D., Sahakian, B.J., Hodges, J.R., Rosser, A.E., Lange, K.W. and Robbins, T.W. (1996) Executive and mnemonic functions in early Huntington's disease. Brain, 119, 1633-1645.
6. Lawrence, A.D., Hodges, J.R., Rosser, A.E., Kershaw, A., Ffrench-Constant, C., Rubinsztein, D.C., Robbins, T.W. and Sahakian, B.J. (1998) Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121, 1329-1341.
7. Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E. and Dom, R. (2004) Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation-a longitudinal follow-up study. J. Neurol., 251, 935-942.
8. Giralt, A., Rodrigo, T., Martin, E.D., Gonzalez, J.R., Mila, M., Cena, V., Dierssen, M., Canals, J.M. and Alberch, J. (2009) Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression. Neuroscience, 158, 1234-1250.
9. Lione, L.A., Carter, R.J., Hunt, M.J., Bates, G.P., Morton, A.J. and Dunnett, S.B. (1999) Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci., 19, 10428-10437.
10. Trueman, R.C., Brooks, S.P., Jones, L. and Dunnett, S.B. (2007) The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington's disease. Eur. J. Neurosci., 25, 551-558.
11. Van Raamsdonk, J.M., Pearson, J., Slow, E.J., Hossain, S.M., Leavitt, B.R. and Hayden, M.R. (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci., 25, 4169-4180.
12. Cummings, D.M., Milnerwood, A.J., Dallerac, G.M., Waights, V., Brown, J.Y., Vatsavayai, S.C., Hirst, M.C. and Murphy, K.P. (2006) Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. Hum. Mol. Genet., 15, 2856-2868.
13. Cummings, D.M., Milnerwood, A.J., Dallerac, G.M., Vatsavayai, S.C., Hirst, M.C. and Murphy, K.P. (2007) Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease. Brain Res. Bull., 72, 103-107.
14. Kung, V.W., Hassam, R., Morton, A.J. and Jones, S. (2007) Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease. Neuroscience, 146, 1571-1580.
15. Lynch, G., Kramar, E.A., Rex, C.S., Jia, Y., Chappas, D., Gall, C.M. and Simmons, D.A. (2007) Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J. Neurosci., 27, 4424-4434.
16. Milnerwood, A.J., Cummings, D.M., Dallerac, G.M., Brown, J.Y., Vatsavayai, S.C., Hirst, M.C., Rezaie, P. and Murphy, K.P. (2006) Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Hum. Mol. Genet., 15, 1690-1703.
17. Murphy, K.P., Carter, R.J., Lione, L.A., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. and Morton, A.J. (2000) Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J. Neurosci., 20, 5115-5123.
18. Kennedy, M.B., Beale, H.C., Carlisle, H.J. and Washburn, L.R. (2005) Integration of biochemical signalling in spines. Nat. Rev. Neurosci., 6, 423-434.
19. Abel, T. and Nguyen, P.V. (2008) Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. Prog. Brain Res., 169, 97-115.
20. Kandel, E.R. and Pittenger, C. (1999) The past, the future and the biology of memory storage. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 354, 2027-2052.
21. Adams, J.P. and Sweatt, J.D. (2002) Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu. Rev. Pharmacol. Toxicol., 42, 135-163.
22. Colbran, R.J. (2004) Protein phosphatases and calcium/ calmodulin-dependent protein kinase II-dependent synaptic plasticity. J. Neurosci., 24, 8404-8409.
23. Malleret, G., Haditsch, U., Genoux, D., Jones, M.W., Bliss, T.V., Vanhoose, A.M., Weitlauf, C., Kandel, E.R., Winder, D.G. and Mansuy, I.M. (2001) Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell, 104, 675-686.
24. Dere, E., Huston, J.P. and de Souza Silva, M.A. (2007) The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci. Biobehav. Rev., 31, 673-704.
25. Gerlai, R. (2001) Behavioral tests of hippocampal function: simple paradigms complex problems. Behav. Brain Res., 125, 269-277.
26. Pang, T.Y., Stam, N.C., Nithianantharajah, J., Howard, M.L. and Hannan, A.J. (2006) Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience, 141, 569-584.
27. Wood, E.R., Dudchenko, P.A., Robitsek, R.J. and Eichenbaum, H. (2000) Hippocampal neurons encode information about different types of memory episodes occurring in the same location. Neuron, 27, 623-633.
28. Vorhees, C.V. and Williams, M.T. (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc., 1, 848-858.
29. Mansuy, I.M., Mayford, M., Jacob, B., Kandel, E.R. and Bach, M.E. (1998) Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell, 92, 39-49.
30. Riedel, G. (1999) If phosphatases go up, memory goes down. Cell Mol. Life Sci., 55, 549-553.
31. Cheng, X., Ma, Y., Moore, M., Hemmings, B.A. and Taylor, S.S. (1998) Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase. Proc. Natl Acad. Sci. USA, 95, 9849-9854.
32. Chen, B.S. and Roche, K.W. (2007) Regulation of NMDA receptors by phosphorylation. Neuropharmacology, 53, 362-368.
33. Niewoehner, B., Single, F.N., Hvalby, O., Jensen, V., Meyer zum Alten, B.S., Seeburg, P.H., Rawlins, J.N., Sprengel, R. and Bannerman, D.M. (2007) Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur. J. Neurosci., 25, 837-846.
34. Tingley, W.G., Ehlers, M.D., Kameyama, K., Doherty, C., Ptak, J.B., Riley, C.T. and Huganir, R.L. (1997) Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J. Biol. Chem., 272, 5157-5166.
35. Brambilla, R., Gnesutta, N., Minichiello, L., White, G., Roylance, A.J., Herron, C.E., Ramsey, M., Wolfer, D.P., Cestari, V., Rossi-Arnaud, C. et al. (1997) A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature, 390, 281-286.
36. Braithwaite, S.P., Paul, S., Nairn, A.C. and Lombroso, P.J. (2006) Synaptic plasticity: one STEP at a time. Trends Neurosci., 29, 452-458.
37. Paul, S., Snyder, G.L., Yokakura, H., Picciotto, M.R., Nairn, A.C. and Lombroso, P.J. (2000) The Dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway. J. Neurosci., 20, 5630-5638.
38. Wang, J.Z. and Liu, F. (2008) Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog. Neurobiol., 85, 148-175.
39. Scott, C.W., Spreen, R.C., Herman, J.L., Chow, F.P., Davison, M.D., Young, J. and Caputo, C.B. (1993) Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J. Biol. Chem., 268, 1166-1173.
40. Ariano, M.A., Aronin, N., DiFiglia, M., Tagle, D.A., Sibley, D.R., Leavitt, B.R., Hayden, M.R. and Levine, M.S. (2002) Striatal neurochemical changes in transgenic models of Huntington's disease. J. Neurosci. Res., 68, 716-729.
41. Cha, J.H., Kosinski, C.M., Kerner, J.A., Alsdorf, S.A., Mangiarini, L., Davies, S.W., Penney, J.B., Bates, G.P. and Young, A.B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc. Natl Acad. Sci. USA, 95, 6480-6485.
42. Jakel, R.J. and Maragos, W.F. (2000) Neuronal cell death in Huntington's disease: a potential role for dopamine. Trends Neurosci., 23, 239-245.
43. Luthi-Carter, R., Strand, A., Peters, N.L., Solano, S.M., Hollingsworth, Z.R., Menon, A.S., Frey, A.S., Spektor, B.S., Penney, E.B., Schilling, G. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet., 9, 1259-1271.
44. Reneerkens, O.A., Rutten, K., Steinbusch, H.W., Blokland, A. and Prickaerts, J. (2009) Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology, 202, 419-443.
45. Canals, J.M., Pineda, J.R., Torres-Peraza, J.F., Bosch, M., Martin-Ibanez, R., Munoz, M.T., Mengod, G., Ernfors, P. and Alberch, J. (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J. Neurosci., 24, 7727-7739.
46. Carter, R.J., Lione, L.A., Humby, T., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. and Morton, A.J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci., 19, 3248-3257.
47. ′-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem. J., 251, 757-762.
48. Simmons, D.A., Rex, C.S., Palmer, L., Pandyarajan, V., Fedulov, V., Gall, C.M. and Lynch, G. (2009) Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc. Natl Acad. Sci. USA, 106, 4906-4911.
49. Nithianantharajah, J., Barkus, C., Murphy, M. and Hannan, A.J. (2008) Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol. Dis., 29, 490-504.
50. Bernabeu, R., Bevilaqua, L., Ardenghi, P., Bromberg, E., Schmitz, P., Bianchin, M., Izquierdo, I. and Medina, J.H. (1997) Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats. Proc. Natl Acad. Sci. USA, 94, 7041-7046.
51. Arnsten, A.F., Ramos, B.P., Birnbaum, S.G. and Taylor, J.R. (2005) Protein kinase A as a therapeutic target for memory disorders: rationale and challenges. Trends Mol. Med., 11, 121-128.
52. Bourtchouladze, R., Patterson, S.L., Kelly, M.P., Kreibich, A., Kandel, E.R. and Abel, T. (2006) Chronically increased Gsalpha signaling disrupts associative and spatial learning. Learn. Mem., 13, 745-752.
53. Horiuchi, J., Yamazaki, D., Naganos, S., Aigaki, T. and Saitoe, M. (2008) Protein kinase A inhibits a consolidated form of memory in Drosophila. Proc. Natl Acad. Sci. USA, 105, 20976-20981.
54. Kelly, M.P., Cheung, Y.F., Favilla, C., Siegel, S.J., Kanes, S.J., Houslay, M.D. and Abel, T. (2008) Constitutive activation of the G-protein subunit Galphas within forebrain neurons causes PKA-dependent alterations in fear conditioning and cortical Arc mRNA expression. Learn. Mem., 15, 75-83.
55. Pineda, V.V., Athos, J.I., Wang, H., Celver, J., Ippolito, D., Boulay, G., Birnbaumer, L. and Storm, D.R. (2004) Removal of G(ialpha1) constraints on adenylyl cyclase in the hippocampus enhances LTP and impairs memory formation. Neuron, 41, 153-163.
56. Ramos, B.P., Birnbaum, S.G., Lindenmayer, I., Newton, S.S., Duman, R.S. and Arnsten, A.F. (2003) Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron, 40, 835-845.
57. Yamazaki, D., Horiuchi, J., Miyashita, T. and Saitoe, M. (2010) Acute inhibition of PKA activity at old ages ameliorates age-related memory impairment in Drosophila. J. Neurosci., 30, 15573-15577.
58. Hebb, A.L., Robertson, H.A. and Denovan-Wright, E.M. (2004) Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms. Neuroscience, 123, 967-981.
59. Hu, H., McCaw, E.A., Hebb, A.L., Gomez, G.T. and Denovan-Wright, E.M. (2004) Mutant huntingtin affects the rate of transcription of striatum-specific isoforms of phosphodiesterase 10A. Eur. J. Neurosci., 20, 3351-3363.
60. Rutten, K., Misner, D.L., Works, M., Blokland, A., Novak, T.J., Santarelli, L. and Wallace, T.L. (2008) Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice. Eur. J. Neurosci., 28, 625-632.
61. Gong, B., Cao, Z., Zheng, P., Vitolo, O.V., Liu, S., Staniszewski, A., Moolman, D., Zhang, H., Shelanski, M. and Arancio, O. (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell, 126, 775-788.
62. Cheng, Y.F., Wang, C., Lin, H.B., Li, Y.F., Huang, Y., Xu, J.P. and Zhang, H.T. (2010) Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25-35 or Abeta1-40 peptide in rats. Psychopharmacology, 212, 181-191.
63. Gong, B., Vitolo, O.V., Trinchese, F., Liu, S., Shelanski, M. and Arancio, O. (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J. Clin. Invest., 114, 1624-1634.
64. Nguyen, P.V. and Woo, N.H. (2003) Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog. Neurobiol., 71, 401-437.
65. Yang, H., Cooley, D., Legakis, J.E., Ge, Q., Andrade, R. and Mattingly, R.R. (2003) Phosphorylation of the Ras-GRF1 exchange factor at Ser916/ 898 reveals activation of Ras signaling in the cerebral cortex. J. Biol. Chem., 278, 13278-13285.
66. Hopf, F.W. and Bonci, A. (2009) Striatal-enriched protein-tyrosine-phosphatase, synaptic plasticity, and psychostimulant-induced stereotypies. Biol. Psychiatry, 65, 635-636.
67. Weingarten, M.D., Lockwood, A.H., Hwo, S.Y. and Kirschner, M.W. (1975) A protein factor essential for microtubule assembly. Proc. Natl Acad. Sci. USA, 72, 1858-1862.
68. Montminy, M.R. and Bilezikjian, L.M. (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature, 328, 175-178.
69. Bender, A.T. and Beavo, J.A. (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol. Rev., 58, 488-520.
70. Pidoux, G. and Tasken, K. (2010) Specificity and spatial dynamics of protein kinase A signaling organized by A-kinase-anchoring proteins. J. Mol. Endocrinol., 44, 271-284.
71. Huang, L., Killbride, J., Rowan, M.J. and Anwyl, R. (1999) Activation of mGluRII induces LTD via activation of protein kinase A and protein kinase C in the dentate gyrus of the hippocampus in vitro. Neuropharmacology, 38, 73-83.
72. Huang, L.Q., Rowan, M.J. and Anwyl, R. (1999) Role of protein kinases A and C in the induction of mGluR-dependent long-term depression in the medial perforant path of the rat dentate gyrus in vitro. Neurosci. Lett., 274, 71-74.
73. Navakkode, S., Sajikumar, S. and Frey, J.U. (2005) Mitogen-activated protein kinase-mediated reinforcement of hippocampal early long-term depression by the type IV-specific phosphodiesterase inhibitor rolipram and its effect on synaptic tagging. J. Neurosci., 25, 10664-10670.
74. Li, S., Tian, X., Hartley, D.M. and Feig, L.A. (2006) Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression. J. Neurosci., 26, 1721-1729.
75. Ariano, M.A., Wagle, N. and Grissell, A.E. (2005) Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes. J. Neurosci. Res., 80, 634-645.
76. Saavedra, A., Giralt, A., Rue, L., Xifro, X., Xu, J., Ortega, Z., Lucas, J.J., Lombroso, P.J., Alberch, J. and Perez-Navarro, E. (2011) STriatal-Enriched protein tyrosine Phosphatase expression and activity in Huntington's disease - a STEP in the resistance to excitotoxicity. J. Neurosci. Doi:10.1523/JNEUROSCI.3446-10.2011.
77. Torres-Peraza, J.F., Giralt, A., Garcia-Martinez, J.M., Pedrosa, E., Canals, J.M. and Alberch, J. (2008) Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling. Neurobiol. Dis., 29, 409-421.
78. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S.W. et al. (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell, 87, 493-506.
79. Saavedra, A., Garcia-Martinez, J.M., Xifro, X., Giralt, A., Torres-Peraza, J.F., Canals, J.M., Diaz-Hernandez, M., Lucas, J.J., Alberch, J. and Perez-Navarro, E. (2010) PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum. Cell Death Differ., 17, 324-335.
80. Xifro, X., Giralt, A., Saavedra, A., Garcia-Martinez, J.M., Diaz-Hernandez, M., Lucas, J.J., Alberch, J. and Perez-Navarro, E. (2009) Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: role in excitotoxicity. Neurobiol. Dis., 36, 461-469.
81. Garcia-Martinez, J.M., Perez-Navarro, E., Xifro, X., Canals, J.M., Diaz-Hernandez, M., Trioulier, Y., Brouillet, E., Lucas, J.J. and Alberch, J. (2007) BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease. J. Neurosci. Res., 85, 2756-2769.